What are the top competitors of Fresenius SE & Co. KGaA in Healthcare sector?

The top competitors of Fresenius SE & Co. KGaA in the Healthcare sector are: EssilorLuxottica S.A. (EI.SW), Edwards Lifesciences Corporation (EW.SW).

Which has better valuations & earnings, Fresenius SE & Co. KGaA or its competitors?

Fresenius SE & Co. KGaA has a market cap of 15.7B and a Dividend Yield of 1.76% compared to its competitors.

Which stock is more profitable: Fresenius SE & Co. KGaA or its competitors?

Fresenius SE & Co. KGaA has an EPS of CHF3.27, while EI.SW has an EPS of CHF3.34. So, Fresenius SE & Co. KGaA is more profitable compared to EI.SW.

What is Fresenius SE & Co. KGaA stock volatility and risk in terms of investment?

Volatility information is not available.

Is Fresenius SE & Co. KGaA stock profitable?

Fresenius SE & Co. KGaA has a Return on Equity (ROE) of 0.04%. So, Fresenius SE & Co. KGaA is more profitable.

What is Fresenius SE & Co. KGaA stock’s 52 weeks high and low?

Fresenius SE & Co. KGaA stock has a 52-week high of (CHF53.06) and a low of (CHFN/A).

What was the average volume of Fresenius SE & Co. KGaA stock?

The average volume of Fresenius SE & Co. KGaA is (-) in terms of investment.

Fresenius SE & Co. KGaA

Get $10 bonus on your first $100 deposit for FRE.SW

FRE.SW•SIX

Healthcare

Medical - Specialties

Get $10 bonus on your first $100 deposit for FRE.SW

CHF53.05

CHF0.00(0.00%)

Swiss Market is Open • 15:05

Fresenius SE & Co. KGaA (FRE.SW) Stock Competitors & Peer Comparison

See (FRE.SW) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Specialties Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

Symbol	Price	Change %	Market Cap	P/E Ratio	EPS	Dividend Yield
FRE.SW	CHF 53.05	+0.00%	15.7B	16.21	CHF 3.27	+1.76%
EI.SW	CHF 117.00	+0.00%	88.1B	35.06	CHF 3.34	+1.91%
EW.SW	CHF 188.26	N/A	0	N/A	N/A	N/A

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

FRE.SW vs EI.SW Comparison April 2026

FRE.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, FRE.SW stands at 15.7B. In comparison, EI.SW has a market cap of 88.1B. Regarding current trading prices, FRE.SW is priced at CHF 53.05, while EI.SW trades at CHF 117.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

FRE.SW currently has a P/E ratio of 16.21, whereas EI.SW's P/E ratio is 35.06. In terms of profitability, FRE.SW's ROE is +0.04%, compared to EI.SW's ROE of +0.06%. Regarding short-term risk, Volatility data is not available for a full comparison. FRE.SW has daily volatility of N/A and EI.SW has daily volatility of 0.00.Check EI.SW's competition here